Clinical Study of Pereutaneous Laser Disc Decompression Compound Radiofrequency Target Thermocoagulation Ablation to Treat Lumbar Disc Herniation

Zhenhua Z, Yi D, Shuo D, Sanbao, Shaodong X and Jun Yin*

Department of Anesthesiology and Pain, Jiashan First People's Hospital, Zhejiang Province, China

^*Correspondance to: Jun Yin 

 PDF  Full Text DOI: 10.25107/2474-1647.2779

Abstract

Objective: To evaluate the clinical effects and safety of Percutaneous Laser Disc Decompression (PLDD) compound radiofrequency targeted thermocoagulation ablation on Lumbar Disc Herniation (LDH). Methods: One hundred and ten patients diagnosed with LDH were selected and divided into two groups. Group A (55 cases) underwent PLDD and radiofrequency targeted thermocoagulation ablation, and Group B (55 cases) underwent PLDD alone. All patients were followed up for 6 to 27 months after the treatment, and the clinical results were assessed separately according to the improved Macnab standard. The adverse reactions were compared between the two groups. Results: The excellent rate of group A was higher than that of group B (P<0.05), but showed no significant difference between the two groups in the effective rate (P>0.05). Conclusion: PLDD combined with radiofrequency targeted thermocoagulation ablation is a better minimally invasive therapy for LDH treatment, which has a higher excellent rate and lower adverse reactions.

Keywords

Lumbar disc herniation; Laser disc decompression; Radiofrequency targeted thermocoagulation ablation

Cite the article

Zhenhua Z, Yi D, Shuo D, Sanbao, Shaodong X, Jun Yin. Clinical Study of Pereutaneous Laser Disc Decompression Compound Radiofrequency Target Thermocoagulation Ablation to Treat Lumbar Disc Herniation. Clin Surg. 2020; 5: 2779..